Results 161 to 170 of about 376,485 (206)

Paradoxical morphea-like reaction after initiation of dupilumab for nodular prurigo. [PDF]

open access: yesAn Bras Dermatol
González Fernández J   +5 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Dermatoses of the Foot

Pediatrics In Review, 1985
Diagnosis of skin conditions restricted to certain body regions may be difficult. Those of the foot may present a considerable problem to the practicing pediatrician, as indicated by a study that demonstrated that although athlete's foot, or tinea pedis,
W. Weston
semanticscholar   +2 more sources

Spectrum of Dermatoses and Infections Affecting the Lower Leg and Foot in an Outpatient Clinic at a Tertiary Care Hospital

Advances in Skin & Wound Care
BACKGROUND Infections and dermatoses of the lower leg and foot can be attributed to factors such as blood stagnation, chemical contact, and abnormal mechanics.
Shanta Passi, Deepika Uikey, Manoj Kumar
semanticscholar   +3 more sources

Common pediatric foot dermatoses.

Journal of Pediatric Health Care, 1999
The pediatric foot dermatoses known as tinea pedis, shoe dermatitis, and juvenile plantar dermatosis are seen commonly in clinical practice. A knowledge of the clinical presentations and causes of these disorders can help pediatric and family nurse practitioners identify, diagnose, and treat childhood rashes of the feet.
Barbara J. Guenst
semanticscholar   +3 more sources

Narrowband ultraviolet‐B phototherapy for hand and foot dermatoses

Photodermatology, Photoimmunology & Photomedicine, 2008
J. Kuhl, M. Davis, M. McEvoy
semanticscholar   +3 more sources

The efficacy of localized PUVA therapy for chronic hand and foot dermatoses

Clinical and Experimental Dermatology, 1994
The response to treatment of all patients enrolled over an 18-month period for localized oral or topical psoralen photochemotherapy (PUVA) of chronic hand and foot dermatoses was retrospectively reviewed. There were broadly similar success rates for the two groups for complete clearance: 61.5% (eight of 13 patients who completed therapy)--oral PUVA, 47.
J. Hawk, P. Grice
semanticscholar   +3 more sources

Home - About - Disclaimer - Privacy